 So, that's for my contribution, we have some time for a few questions on technology ethics and economy in healthcare. Yes. Thank you very much. My name is Randy Cotier, I'm a graduate student at the Kennedy School and an incoming French public servant. My question is, during COVID we've seen how technology has become a key and strategic capability, but the question is, who should develop those technologies and who should own them? Should it be the private sector for maybe efficiency concerns and also for the fact that there will be more independence on that or should it be more on the state side for ethics concerns actually? Because people would maybe trust various states more in some places or in other places would be more. Apple, Facebook. Thank you very much. Thank you, Jacques. You want to take the question? Yeah. Well, thanks for the great question. Actually, I think I gave a pretty pessimistic view of the regulation of the system, but there are good news and the good news is that there is plenty, there's a big reservoir of productivity due to augmented intelligence, which would make it possible to get rid of many of the inefficiency in the system. Now, the question of who owns that is a big question, you know, and again we lack time and I think this would be an encouragement to Thierry to go ahead with more thoughts being given by E3 to healthcare issues. I currently have a project, for instance, which leads to roll out artificial intelligence into pathology and the question is who owns that? Is it the engineer, the physician, the people who provided the data which made it possible, the hospital, et cetera? So it's a big question. We don't have much time. I think in the end the profit has to be shared between the various players. Once again, the good news is that there is a reservoir of productivity and so we should all work together, first of all, to see how it is possible to really grasp this reservoir and how we share it in an intelligent way and in an equitable way. So I defer this question to another meeting, Thierry, if you are interested in going ahead with this theme. We have a question from Michel as chairman of the previous panel. I wonder what you have to say. Thank you very much. It's a question to Dr. Keeman, Carlos Moreira, maybe, I think beyond the technological progress and beyond the issue of consent, I think what you've been talking about is a major revolution to me, which is that these technologies will lead to self-responsible management of health by the people. Until now, the patient somehow, and the name patient, the word patient is speaking by itself, was a passive object versus the healthcare system. Now the patient will become the responsible actor, and that, of course, has a lot of implications in terms of what's his source of information and whether we should leave the decision to the patient. And I wonder whether you can comment on that. Can I go first? Yeah, is that a question for me? I will go first. Actually, in the diagnostic field, there is a self-testing system. The rapid immunosake kit is one of the examples. So the FDA has a process for self-testing for a clear test, clear wave of the test, that kind of things can be done by simple process. For example, if you have the one drop of blood, and then you can see the band, one band or two band. If you have a single band that is negative, if you see the double band, it's positive, very simple for the determination. That kind of simple system can be applicable at home. If I just completing the answer, I think that it needs regulation. The fact of moving from passive, which is what we should be, to be an automatic default login into somebody assessing our health, is something that can only be resolved by legislation. You know, there's HIPAA regulation in the United States, there's other regulation in Europe, but that's actually very vague in who owns the data. The data should be owned by HOS, by the patient, not by the system. If we own the data and it's under our consent, then we have our protection. As we have it everywhere else, we have it in the financial system, right? The bank is not authorized to do anything without our consent. That level of consent needs to be installed in the health industry. Now it's not the case. Now the data belongs to the health institution, and this is wrong. The data should belong to HOS, and we can give them their consent to use that data. If the data belongs to them by default, then by default, we will let artificial intelligence and other technologies to data mine that data. Okay, thank you. I think we come to the end of the session. Thank you very much to my colleague, Panelitz, on the insightful presentation for your question. And as we have the bus in the room, I would not dare to overrun, so... Thank you very much.